Press release
Endocrine Testing Market Company Analysis and Forecast to 2023
Endocrine testing has been witnessing a widespread application since the last few years. Analysts expect the trend to rise steadily in the near future due to growing prevalence of obesity and diabetes across the world. In 2014, the global opportunity in endocrine testing was worth US$6.1 bn. Rising at a CAGR of 8.50% between 2015 and 2023, it is likely to increase to US$12.8 bn by 2023.Browse the Complete Report Details for this Market at: http://www.transparencymarketresearch.com/endocrine-testing-market.html
The rise in the incidence of diabetes, propelled by the increasing geriatric as well as obese population, has fueled the application of endocrine testing in determining the insulin level in a human body. The prevalence of obesity, in general, has also boosted the demand for this technology significantly, as it leads to a number of life-threatening diseases such as cardiac disorders, stroke, hypertension, and several types of cancer.
Going forward, the unmet medical needs in emerging countries are likely to provide ample opportunities for this market to grow. Leading players are aggressively focusing on expanding their reach in these economies through mergers, acquisitions, and strategic partnerships with local players.
Commercial Laboratories to Remain Leading End User of Endocrine Testing
Physician offices, home-based tests, hospitals, ambulatory care centers, and commercial laboratories are the prime end users of endocrine testing technology. Among these, commercial laboratories acquired the leading position in 2014 and is projected to remain on the top throughout the forecast period. The presence of skilled professionals, increased usage of specialized diagnostics tools, and advanced diagnostics facilities are the prominent factors that have fueled the application of endocrine testing techniques in these laboratories over the recent past.
In near future, the advent of tele-health services is expected to increase the application of endocrine testing in commercial laboratories considerably. The adoption of this technology will also witness a significant rise in the home-based tests segment in the coming years, owing to the instant results provided by endocrine test kits.
Endocrine Testing to Report Fastest Growth Rate in Asia Pacific
The global endocrine testing market stretches across North America, Asia Pacific, Europe, and the Rest of the World. North America emerged as the key contributor to the revenue generated in this market in 2014 with a share of more than 40%. The growing preference for a healthy lifestyle among people has increased the adoption of this technology in this region.
Additionally, the continual advancements in technology are expected to escalate the application of endocrine testing in North America over the next few years. Asia Pacific, however, is likely to provide the market players with most promising opportunities in the near future, owing to the presence of untapped emerging countries. The demand for endocrine testing in Asia Pacific is anticipated to rise at the fastest CAGR of 10.30% during the period from 2015 to 2023.
Get the Sample PDF Report Containing the Upcoming Market Oppotunities at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1645
F-Hoffmann La Roche Ltd. and Abbott Laboratories lead the global market for endocrine testing. Other key players operating in this market are DiaSorin S.p.A., Bio-Rad Laboratories Inc., bioMerieux SA, Biomedical Diagnostics, Agilent Technologies, AB Sciex Pte. Ltd., LabCorp, Siemens AG, and Thermo Fisher Scientific Inc.
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endocrine Testing Market Company Analysis and Forecast to 2023 here
News-ID: 510728 • Views: …
More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…

North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…

Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…

Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Endocrine
Endocrine Testing: A Leading Driver Behind Impact of Diabetes Prevalence on Endo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Endocrine Testing Industry Market Size Be by 2025?
In recent times, there has been a significant expansion in the size of the endocrine testing market. The market is projected to expand from $2.55 billion in 2024 to $2.8 billion in 2025, reflecting a compound annual growth…
Evolving Market Trends In The Endocrine Peptide Test Industry: Advancements in I …
The Endocrine Peptide Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Endocrine Peptide Test Market Size During the Forecast Period?
The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to…
Key Influencer in the Endocrine Testing Market 2025: Impact of Diabetes Prevalen …
What industry-specific factors are fueling the growth of the endocrine testing market?
The growing prevalence of diabetes is also expected to drive the endocrine testing market. Similar to the peptide tests, endocrine testing is crucial for diagnosing, monitoring, and managing diabetes. As the disease becomes more prevalent, especially among younger populations, the demand for these diagnostic tests increases. According to NHS data from June 2024, diabetes diagnoses in individuals under 40…
Key Influencer in the Endocrine Peptide Test Market 2025: Impact of Diabetes Pre …
What Is the Forecasted Market Size and Growth Rate for the Endocrine Peptide Test Market?
The market size for endocrine peptide tests has significantly expanded in the recent past. The growth is slated to rise from $9.11 billion in 2024 to a significant $9.97 billion in 2025. This translates to a compound annual growth rate (CAGR) of 9.5%. The expansion during the historic phase is linked to factors like increased government…
Impact of Diabetes Prevalence on Endocrine Testing Market Growth Driver: Leading …
"What Are the Projected Growth and Market Size Trends for the Endocrine Testing Market?
In the past few years, the endocrine testing market has seen a significant expansion. The market, which is worth $2.55 billion in 2024, is projected to reach $2.8 billion in the following year, growing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the historic period include the discovery of hormones…
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is…